The Carlyle Group Inc. (CG) 13D/13G Filings for Vaxcyte, Inc. (PCVX)

The Carlyle Group Inc. 13D and 13G filings for Vaxcyte, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-10
4:14 pm
Purchase
2022-12-3113GVaxcyte, Inc.
PCVX
Carlyle Group Inc.
CG
2,070,724
2.600%
2,070,724increase
(New Position)
Filing